Get started
PROFOUND MED CORPPROFOUND MED CORPPROFOUND MED CORP

PROFOUND MED CORP

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Forecast Seasonals

PRN chart


Full chart

PRN upcoming earnings


Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪198.56 M‬ CAD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−1.54 CAD
Net income (FY)
‪−38.11 M‬ CAD
Revenue (FY)
‪14.63 M‬ CAD
Shares float
‪26.63 M‬
Beta (1Y)
1.35

Employees


Employees (FY)
142
Change (1Y)
+11 +8.40%
Revenue / Employee (1Y)
‪103.04 K‬ CAD
Net income / Employee (1Y)
‪−268.36 K‬ CAD

About PROFOUND MED CORP


Sector
Health Technology
Industry
Medical Specialties
CEO
Arun S. Menawat
Website
profoundmedical.com
Headquarters
Mississauga
Founded
2008
FIGI
BBG0076T0BV5
Profound Medical Corp. is a commercial-stage medical device company focused on the development and marketing of customizable, incision-free therapeutic systems for the ablation of diseased tissue utilizing its platform technologies. The firm’s product, the TULSA-PRO system, combines real-time MRI, robotically driven transurethral sweeping action/thermal ultrasound, and closed-loop temperature feedback control to ablate whole gland or physician defined region of malignant or benign prostate tissue. It is also focused on developing Sonalleve, a therapeutic platform that is CE marked for the treatment of uterine fibroids and palliative pain treatment of bone metastases. The company was founded on June 13, 2008 and is headquartered in Mississauga, Canada.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

PRN news



Ideas



See all ideas 

Technicals


Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Check out other big names from the same industry as PRN.

Frequently Asked Questions


The current price of PRN is 6.46 CAD — it has decreased by −0.75% in the past 24 hours. Watch PROFOUND MED CORP stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on TSX exchange PROFOUND MED CORP stocks are traded under the ticker PRN.
PRN stock has risen by 4.59% compared to the previous week, the month change is a −31.57% fall, over the last year PROFOUND MED CORP has showed a −38.59% decrease.
We've gathered analysts' opinions on PROFOUND MED CORP future price: according to them, PRN price has a max estimate of 24.41 CAD and a min estimate of 16.51 CAD. Watch PRN chart and read a more detailed PROFOUND MED CORP stock forecast: see what analysts think of PROFOUND MED CORP and suggest that you do with its stocks.
PRN reached its all-time high on Feb 8, 2021 with the price of 36.73 CAD, and its all-time low was 4.21 CAD and was reached on Oct 26, 2022. View more price dynamics on PRN chart.
See other stocks reaching their highest and lowest prices.
PRN stock is 9.91% volatile and has beta coefficient of 1.35. Track PROFOUND MED CORP stock price on the chart and check out the list of the most volatile stocks — is PROFOUND MED CORP there?
Today PROFOUND MED CORP has the market capitalization of ‪198.56 M‬, it has increased by 6.47% over the last week.
Yes, you can track PROFOUND MED CORP financials in yearly and quarterly reports right on TradingView.
PROFOUND MED CORP is going to release the next earnings report on May 8, 2025. Keep track of upcoming events with our Earnings Calendar.
PRN earnings for the last quarter are −0.29 CAD per share, whereas the estimation was −0.46 CAD resulting in a 37.98% surprise. The estimated earnings for the next quarter are −0.41 CAD per share. See more details about PROFOUND MED CORP earnings.
PROFOUND MED CORP revenue for the last quarter amounts to ‪6.01 M‬ CAD, despite the estimated figure of ‪6.08 M‬ CAD. In the next quarter, revenue is expected to reach ‪4.79 M‬ CAD.
PRN net income for the last quarter is ‪−6.92 M‬ CAD, while the quarter before that showed ‪−12.77 M‬ CAD of net income which accounts for 45.85% change. Track more PROFOUND MED CORP financial stats to get the full picture.
No, PRN doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Apr 21, 2025, the company has 142 employees. See our rating of the largest employees — is PROFOUND MED CORP on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. PROFOUND MED CORP EBITDA is ‪−44.01 M‬ CAD, and current EBITDA margin is −300.81%. See more stats in PROFOUND MED CORP financial statements.
Like other stocks, PRN shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade PROFOUND MED CORP stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So PROFOUND MED CORP technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating PROFOUND MED CORP stock shows the strong sell signal. See more of PROFOUND MED CORP technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.